ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ASLN ASLAN Pharmaceuticals Ltd

0.60
0.00 (0.00%)
20 Dec 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
TWD (TWD)TWD (TWD)TWD (TWD)TWD (TWD)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000012M000
Operating Income -12.45M-10.37M-13.44M-18.11M-2.36M-10.42M-12.85M-9.29M
Pre Tax Income -13.04M-10.91M-14.4M-19.11M-1.83M-9.68M-13.47M-9.92M
Net Income -13.04M-10.93M-14.48M-19.11M-1.89M-9.71M-13.51M-9.92M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -12.15M-10.11M-13.86M-18.36M-775k-8.57M-12.15M-9.26M
EBITDA -12.31M-10.52M-13.11M-18.11M-2.35M-10.44M-12.5M-9.29M
Year End 31 December 2023 20162017201820192020202120222023
TWD (TWD)TWD (TWD)TWD (TWD)TWD (TWD)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 373.02M0092.36M00012M
Operating Income -281.04M-1.17B-1.27B-1.41B-16.48M-34.25M-48.32M-43.74M
Pre Tax Income -292.33M-1.21B-1.27B-1.44B-16.97M-31.59M-51.28M-44.09M
Net Income -292.33M-1.21B-1.27B-1.45B-16.2M-31.59M-51.38M-44.22M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.527-9.286-7.931-7.644-0.068-0.097-0.147-0.101
EBIT -280.75M-1.18B-1.27B-1.41B-15.72M-29.73M-47.97M-39.83M
EBITDA -278.59M-1.17B-1.26B-680.68M-16.19M-33.97M-47.99M-43.4M

Your Recent History

Delayed Upgrade Clock